Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2015 Dec 29;112(52):15783-4.
doi: 10.1073/pnas.1521923113. Epub 2015 Dec 16.

Adopting ALK and LTK

Greg Lemke  1
Affiliations
Comment

Adopting ALK and LTK

Greg Lemke. Proc Natl Acad Sci U S A. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Comment on

References

    1. Schlessinger J. Receptor tyrosine kinases: Legacy of the first two decades. Cold Spring Harb Perspect Biol. 2014;6(3):a008912. - PMC - PubMed
    1. Sharma PS, Sharma R, Tyagi T. Receptor tyrosine kinase inhibitors as potent weapons in war against cancers. Curr Pharm Des. 2009;15(7):758–776. - PubMed
    1. Shak S. Herceptin Multinational Investigator Study Group Overview of the trastuzumab (Herceptin) anti-HER2 monoclonal antibody clinical program in HER2-overexpressing metastatic breast cancer. Semin Oncol. 1999;26(4, Suppl 12):71–77. - PubMed
    1. Hunter T. The genesis of tyrosine phosphorylation. Cold Spring Harb Perspect Biol. 2014;6(5):a020644. - PMC - PubMed
    1. Reshetnyak AV, et al. Augmentor α and β (FAM150) are ligands of the receptor tyrosine kinases ALK and LTK: Hierarchy and specificity of ligand–receptor interactions. Proc Natl Acad Sci USA. 2015;112:15862–15867. - PMC - PubMed

Substances

LinkOut - more resources